Role of PET-CT (Positron Emission Tomography-Computed Tomography) in Cancer Evaluation and Treatment
Open Access
- 1 January 2022
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in World Journal of Nuclear Science and Technology
- Vol. 12 (01), 11-20
- https://doi.org/10.4236/wjnst.2022.121002
Abstract
Context: Positron emission tomography is a nuclear medicine imaging that deals with physiological function using radioisotopes. With the most PET (Positron Emission Tomography) scanners in integration with the CT scanners of late, this technology has registered phenomenal growth. The small amount of radioactive material is called Radiotracers. Objective: Like 18F- Fluro-deoxy-2-glucose has widely used. In this article, the author introduced clinical applications of PET out of 25 patients who studied hypermetabolic lesions in lymph nodes. Methods: PET imaging is coincidence imaging which is different from the other imaging technique PET image formed from multiple rings of detector crystals. Each decay positron travel in tissue annihilation reaction is going on. FDG is the most commonly used radiotracer to detect and stage various types of malignancies. Result: The field of PET/CT imaging cares for many oncology patients. PET improved localization of malignant lesions. It improved staging biopsy and therapy. Conclusion: Finally, studies to data showed 4% to 10% improvement in the overall accuracy of staging/restaging in lesions. If we use Monte Carlo simulation, OLINDA/EXM software may improve further with widely used.Keywords
This publication has 13 references indexed in Scilit:
- Clinical Applications of PET and PET-CTMedical Journal Armed Forces India, 2009
- Monitoring of Early Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer by [18F]Fluorodeoxyglucose Positron Emission TomographyJournal of Clinical Oncology, 2006
- Adrenal Lesions: Characterization with Fused PET/CT Image in Patients with Proved or Suspected Malignancy—Initial ExperienceRadiology, 2006
- Diagnostic and Prognostic Value of 18-Fluorodeoxyglucose Positron Emission Tomography in Adrenocortical Carcinoma: A Prospective Comparison with Computed TomographyJournal of Clinical Endocrinology & Metabolism, 2006
- Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian CancerJournal of Clinical Oncology, 2005
- Clinical Applications of PET in OncologyRadiology, 2004
- Thoracic positron emission tomography using18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin diseaseBlood, 2001
- Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomographyThe Annals of Thoracic Surgery, 1995
- Cancer statistics, 1992CA: A Cancer Journal for Clinicians, 1992
- The natural history of lung cancer: A review based on rates of tumour growthRespiratory Medicine, 1979